Defence Therapeutics AAQS 2024
Defence Therapeutics AAQS
2
Ticker
DTC.CN
ISIN
CA24463V1013
WKN
A3CN14
Defence Therapeutics has a current AAQS of 2.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Defence Therapeutics in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Defence Therapeutics Aktienanalyse
What does Defence Therapeutics do?
Defence Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Frequently Asked Questions about Defence Therapeutics stock
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Defence Therapeutics
Our stock analysis for Defence Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Defence Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Defence Therapeutics Revenue
- Defence Therapeutics Net Income
- Defence Therapeutics P/E
- Defence Therapeutics P/S
- Defence Therapeutics EBIT
- Defence Therapeutics Dividend
- Defence Therapeutics Stocks
- Defence Therapeutics Market capitalization
- Defence Therapeutics Debt
- Defence Therapeutics Liabilities
- Defence Therapeutics Equity
- Defence Therapeutics AAQS
- Defence Therapeutics Employees
- Defence Therapeutics ROE
- Defence Therapeutics ROA
- Defence Therapeutics ROCE